
Michael A. Riegelman
Examiner (ID: 12379)
| Most Active Art Unit | 3654 |
| Art Unit(s) | 3654 |
| Total Applications | 1332 |
| Issued Applications | 1022 |
| Pending Applications | 97 |
| Abandoned Applications | 247 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18832011
[patent_doc_number] => 20230400538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => USE OF LACTIC ACID IN HYPERPOLARIZATION FOR MAGNETIC RESONANCE APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/837794
[patent_app_country] => US
[patent_app_date] => 2022-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7396
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17837794
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/837794 | USE OF LACTIC ACID IN HYPERPOLARIZATION FOR MAGNETIC RESONANCE APPLICATIONS | Jun 9, 2022 | Pending |
Array
(
[id] => 19379193
[patent_doc_number] => 20240269063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => Multi-Core Magnetic Metal Oxide Nanoparticles
[patent_app_type] => utility
[patent_app_number] => 18/568411
[patent_app_country] => US
[patent_app_date] => 2022-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13354
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18568411
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/568411 | Multi-Core Magnetic Metal Oxide Nanoparticles | Jun 7, 2022 | Pending |
Array
(
[id] => 19246239
[patent_doc_number] => 20240197223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => ORAL CARE FLAVOUR FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING
[patent_app_type] => utility
[patent_app_number] => 18/555983
[patent_app_country] => US
[patent_app_date] => 2022-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12918
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18555983
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/555983 | ORAL CARE FLAVOUR FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING | May 29, 2022 | Pending |
Array
(
[id] => 19246199
[patent_doc_number] => 20240197183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => ORAL CARE FLAVOUR FOR IMPROVING INVIGORATION STATE AND METHOD OF ASSESSING
[patent_app_type] => utility
[patent_app_number] => 18/556014
[patent_app_country] => US
[patent_app_date] => 2022-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13713
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 373
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18556014
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/556014 | ORAL CARE FLAVOUR FOR IMPROVING INVIGORATION STATE AND METHOD OF ASSESSING | May 29, 2022 | Pending |
Array
(
[id] => 17850620
[patent_doc_number] => 20220280661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => GLUCOCORTICOID RECEPTOR RADIOLIGANDS AND METHODS FOR THEIR PREPARATION AND USE
[patent_app_type] => utility
[patent_app_number] => 17/737649
[patent_app_country] => US
[patent_app_date] => 2022-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19490
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17737649
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/737649 | GLUCOCORTICOID RECEPTOR RADIOLIGANDS AND METHODS FOR THEIR PREPARATION AND USE | May 4, 2022 | Abandoned |
Array
(
[id] => 17805969
[patent_doc_number] => 20220257804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => FILM-FORMING AGENT COMPOSITION FOR CONTRAST AGENT, FILM-FORMING LIPID SOLUTION FOR CONTRAST AGENT, CONTRAST AGENT AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/736759
[patent_app_country] => US
[patent_app_date] => 2022-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7519
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17736759
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/736759 | FILM-FORMING AGENT COMPOSITION FOR CONTRAST AGENT, FILM-FORMING LIPID SOLUTION FOR CONTRAST AGENT, CONTRAST AGENT AND PREPARATION METHOD THEREOF | May 3, 2022 | Pending |
Array
(
[id] => 17931130
[patent_doc_number] => 20220326255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => METHODS OF MONITORING MUCOSAL HEALING
[patent_app_type] => utility
[patent_app_number] => 17/708789
[patent_app_country] => US
[patent_app_date] => 2022-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17708789
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/708789 | METHODS OF MONITORING MUCOSAL HEALING | Mar 29, 2022 | Pending |
Array
(
[id] => 19140559
[patent_doc_number] => 20240139353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => METHODS OF TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/769232
[patent_app_country] => US
[patent_app_date] => 2022-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29550
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769232
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/769232 | METHODS OF TREATING CANCER | Mar 22, 2022 | Abandoned |
Array
(
[id] => 19201519
[patent_doc_number] => 20240173418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => CYCLIC DINUCLEOTIDE CONJUGATES AND RELATED METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/284035
[patent_app_country] => US
[patent_app_date] => 2022-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8045
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18284035
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/284035 | CYCLIC DINUCLEOTIDE CONJUGATES AND RELATED METHODS OF USE THEREOF | Mar 22, 2022 | Pending |
Array
(
[id] => 19316914
[patent_doc_number] => 20240238454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => LUNG LESION LOCALIZATION MULTI-IMAGING CONTRAST AGENT COMPOSITION FOR RESTRICTIVE LUNG RESECTION
[patent_app_type] => utility
[patent_app_number] => 18/276311
[patent_app_country] => US
[patent_app_date] => 2022-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4951
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18276311
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/276311 | LUNG LESION LOCALIZATION MULTI-IMAGING CONTRAST AGENT COMPOSITION FOR RESTRICTIVE LUNG RESECTION | Feb 8, 2022 | Pending |
Array
(
[id] => 17747863
[patent_doc_number] => 20220226066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => Formulation for Gastrointestinal Marking
[patent_app_type] => utility
[patent_app_number] => 17/579666
[patent_app_country] => US
[patent_app_date] => 2022-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579666
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/579666 | Formulation for Gastrointestinal Marking | Jan 19, 2022 | Pending |
Array
(
[id] => 19140553
[patent_doc_number] => 20240139347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => COMPLEX, VASCULAR CONTRAST AGENT, X-RAY CONTRAST AGENT, METHOD FOR PRODUCING COMPLEX, AND IMAGING METHOD FOR CAPTURING STRUCTURAL CHANGE IN VESSEL
[patent_app_type] => utility
[patent_app_number] => 18/262562
[patent_app_country] => US
[patent_app_date] => 2022-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18262562
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/262562 | COMPLEX, VASCULAR CONTRAST AGENT, X-RAY CONTRAST AGENT, METHOD FOR PRODUCING COMPLEX, AND IMAGING METHOD FOR CAPTURING STRUCTURAL CHANGE IN VESSEL | Jan 13, 2022 | Pending |
Array
(
[id] => 17441915
[patent_doc_number] => 20220062420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => METHOD OF PRODUCING A COMPOSITION FOR BORON NEUTRON CAPTURE THERAPY OF MALIGNANT TUMORS (EMBODIMENTS)
[patent_app_type] => utility
[patent_app_number] => 17/525616
[patent_app_country] => US
[patent_app_date] => 2021-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17525616
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/525616 | Method of producing a composition for boron neutron capture therapy of malignant tumors (embodiments) | Nov 11, 2021 | Issued |
Array
(
[id] => 18816066
[patent_doc_number] => 20230390405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => SELECTIVE NERVE CELL DEACTIVATION
[patent_app_type] => utility
[patent_app_number] => 18/035526
[patent_app_country] => US
[patent_app_date] => 2021-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15997
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035526
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/035526 | SELECTIVE NERVE CELL DEACTIVATION | Nov 10, 2021 | Pending |
Array
(
[id] => 17640714
[patent_doc_number] => 20220168452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => TISSUE SPACERS
[patent_app_type] => utility
[patent_app_number] => 17/522674
[patent_app_country] => US
[patent_app_date] => 2021-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17522674
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/522674 | TISSUE SPACERS | Nov 8, 2021 | Pending |
Array
(
[id] => 18860359
[patent_doc_number] => 20230414793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => NANOPARTICLE
[patent_app_type] => utility
[patent_app_number] => 18/035273
[patent_app_country] => US
[patent_app_date] => 2021-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11382
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035273
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/035273 | NANOPARTICLE | Nov 3, 2021 | Pending |
Array
(
[id] => 18971840
[patent_doc_number] => 20240051932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => LABILE AND COHERENT REDOX-SILENT ANALOGUES FOR VITAMIN E ENHANCEMENT
[patent_app_type] => utility
[patent_app_number] => 17/761978
[patent_app_country] => US
[patent_app_date] => 2021-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6202
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761978
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/761978 | LABILE AND COHERENT REDOX-SILENT ANALOGUES FOR VITAMIN E ENHANCEMENT | Oct 26, 2021 | Abandoned |
Array
(
[id] => 18842725
[patent_doc_number] => 20230405129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => PROINFLAMMATORY PRODRUGS
[patent_app_type] => utility
[patent_app_number] => 18/032760
[patent_app_country] => US
[patent_app_date] => 2021-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14292
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18032760
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/032760 | PROINFLAMMATORY PRODRUGS | Oct 19, 2021 | Pending |
Array
(
[id] => 19156210
[patent_doc_number] => 20240148917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => PNA PROBES FOR PRETARGETED IMAGING AND THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/249192
[patent_app_country] => US
[patent_app_date] => 2021-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12561
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18249192
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/249192 | PNA PROBES FOR PRETARGETED IMAGING AND THERAPY | Oct 17, 2021 | Pending |
| 17/498603 | CHEMICAL COMPOUND THAT BINDS TO NERVES WHILE PERMITTING DETECTION VIA COMPUTED TOMOGRAPHY OR X-RAY | Oct 10, 2021 | Abandoned |